Form 4: Veracyte CFO's Tax Withholding on RSU Vesting

Veracyte's Chief Financial Officer, Rebecca Chambers, reported the withholding of 5,371 common shares for tax obligations related to restricted stock unit vesting.

Summary

• Rebecca Chambers, Chief Financial Officer of Veracyte, Inc. (VCYT), reported a transaction on September 2, 2025.
• The transaction involved the disposition of 5,371 shares of common stock at a price of $30.11 per share.
• These shares were withheld to satisfy tax withholding obligations in connection with the vesting of certain restricted stock units.
• This transaction does not represent a sale of shares by the reporting person.
• Following this transaction, Rebecca Chambers beneficially owns 133,158 shares of Veracyte common stock.

Sentiment

Score: 5

Explanation: Neutral. The filing reports a routine tax withholding transaction related to RSU vesting, which is an expected part of executive compensation and does not indicate a change in company fundamentals or strategy.

Positives

• The transaction is a routine tax withholding event, indicating the vesting of restricted stock units, which can be seen as a positive for executive compensation and retention.

Negatives

• No direct negatives are associated with this routine tax withholding transaction.

Risks

• No specific risks are mentioned in this Form 4 filing.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: Minimal direct impact as it is a routine tax withholding, not a market sale. It reflects the ongoing compensation structure for executives.
• Employees: Reflects standard executive compensation practices, which may be consistent with broader employee incentive programs.

Key Dates

Keywords

Veracyte, VCYT, Rebecca Chambers, Chief Financial Officer, CFO, Form 4, insider transaction, restricted stock units, RSU vesting, tax withholding, common stock